Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Other 2Thoracic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 349pembrolizumab 327Pemetrexed 249Cisplatin 220Paclitaxel 150Nivolumab 140durvalumab 135Docetaxel 112osimertinib 110atezolizumab 106Specimen Handling 92Radiotherapy 87Drug Therapy 87Magnetic Resonance Spectroscopy 78Etoposide 77Radiosurgery 72Gemcitabine 72Ipilimumab 56130-nm albumin-bound paclitaxel 54Bevacizumab 53cemiplimab 47tislelizumab 46Blood Specimen Collection 43Taxes 36Cetuximab 34Biopsy 33Standard of Care 32Platinum 32Injections 32Immunoglobulin G 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bupropion × Thoracic × 1 year × Clear all
NCT04694846 2025-09-09

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Thomas Jefferson University

Phase NA Completed
19 enrolled
Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡